INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.310
-0.020 (-1.50%)
At close: Mar 9, 2026, 4:00 PM EDT
1.290
-0.020 (-1.53%)
After-hours: Mar 9, 2026, 7:31 PM EDT
INmune Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 35 | 104 | 203 | 114 | 182 | 232 | |
| Market Cap Growth | -82.72% | -48.97% | 78.35% | -37.48% | -21.41% | 270.69% | |
| Enterprise Value | 10 | 73 | 175 | 72 | 112 | 207 | |
| Last Close Price | 1.33 | 4.67 | 11.26 | 6.34 | 10.20 | 17.22 | |
| PS Ratio | 723.12 | 7396.10 | 1309.19 | 304.22 | 1005.53 | 21052.15 | |
| PB Ratio | 1.39 | 3.23 | 5.32 | 1.89 | 2.27 | 5.98 | |
| P/TBV Ratio | 1.42 | 6.65 | 9.74 | 2.61 | 2.86 | 10.41 | |
| EV/Sales Ratio | 190.04 | 5207.60 | 1127.89 | 191.85 | 619.14 | 18856.25 | |
| Debt / Equity Ratio | 0.04 | 0.01 | 0.27 | 0.26 | 0.19 | 0.00 | |
| Net Debt / Equity Ratio | -1.05 | -0.64 | -0.67 | -0.61 | -0.74 | -0.56 | |
| Asset Turnover | 0.00 | 0 | 0.00 | 0.00 | 0.00 | 0 | |
| Quick Ratio | 4.11 | 3.09 | 2.07 | 5.55 | 18.43 | 13.38 | |
| Current Ratio | 4.17 | 3.14 | 2.16 | 5.92 | 18.95 | 13.51 | |
| Return on Equity (ROE) | -155.77% | -119.83% | -61.09% | -38.91% | -51.00% | -38.80% | |
| Return on Assets (ROA) | -50.59% | -55.19% | -26.78% | -17.85% | -25.92% | -23.47% | |
| Return on Capital Employed (ROCE) | -134.10% | -131.80% | -77.20% | -36.60% | -30.50% | -31.50% | |
| Earnings Yield | -137.98% | -40.64% | -14.79% | -23.99% | -16.67% | -5.22% | |
| Buyback Yield / Dilution | -25.30% | -10.92% | -0.30% | -11.14% | -34.55% | -16.70% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.